MicroRNA frontiers: Illuminating early detection paths in multiple sclerosis

Area of Science:

• Neuroscience
• Biomarker Discovery
• Molecular Biology

Background:

• Multiple sclerosis (MS) is a progressive central nervous system disorder causing demyelination, neuronal loss, and atrophy.
• Current diagnostic and prognostic biomarkers for MS lack reliable correlation with disease progression.
• Distinguishing between inflammatory relapsing-remitting MS (RRMS) and neurodegenerative secondary progressive MS (SPMS) is challenging.

Purpose of the Study:

• To review current research on differences in circulating microRNA (miRNA) panel expression across multiple sclerosis (MS) disease phases.
• To explore the potential of miRNAs as diagnostic and prognostic biomarkers for MS.
• To investigate how miRNA expression patterns may inform strategies for halting MS disability advancement.

Main Methods:

• Review of existing scientific literature on microRNA expression in multiple sclerosis.
• Analysis of studies comparing miRNA profiles in relapsing-remitting MS (RRMS) and secondary progressive MS (SPMS) patients.
• Examination of the correlation between miRNA expression patterns and disease stage/activity.

Main Results:

• Circulating microRNAs (miRNAs) exhibit altered expression patterns across the multiple sclerosis (MS) disease spectrum.
• Differential expression of miRNA panels between RRMS and SPMS suggests potential as distinct biomarkers.
• These findings highlight miRNAs as promising candidates for monitoring MS progression and activity.

Conclusions:

• Circulating microRNAs represent a promising avenue for improving multiple sclerosis (MS) diagnosis and prognosis.
• Analyzing miRNA panels could provide critical insights into the transition from RRMS to SPMS.
• Further research into miRNA expression may lead to targeted therapies to mitigate MS-related disability.